Autoimmune disease-relevant peptides can induce antigen-specific regulatory T cells and reverse autoimmune inflammation, as shown in mice humanized with lymphocytes from type 1 diabetes and treated with nanoparticles coated with human GAD65 (Clemente-Casares et al., 2016). This evidence concerns the gene GAD2 and type 1 diabetes mellitus.